Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort study-Reference-Cited by-同舟云学术

Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort study

Published:2015-07-25 Issue:3 Volume:55 Page:265-277
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Labori Knut J.¹,Katz Matthew H.²,Tzeng Ching W.³,Bjørnbeth Bjørn A.¹,Cvancarova Milada⁴,Edwin Bjørn⁵⁶,Kure Elin H.⁷,Eide Tor J.⁶⁸,Dueland Svein⁹,Buanes Trond¹⁶,Gladhaug Ivar P.¹⁶

Affiliation:

1. Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway

2. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

3. Department of Surgery, University of Kentucky, Lexington, Kentucky, USA

4. Department of Oncology, National Resource Center for Late Effects, Oslo University Hospital, Oslo, Norway

5. Intervention Centre, Rikshospitalet, Oslo University Hospital, Oslo, Norway

6. Institute of Clinical Medicine, University of Oslo, Oslo, Norway

7. Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

8. Department of Pathology, Oslo University Hospital, Oslo, Norway

9. Department of Oncology, Oslo University Hospital, Oslo, Norway

Publisher

Informa UK Limited